United States · FDA National Drug Code directory

Baxter Healthcare Company

Labeler · 121 source records

The organisation role is retained from the source. Companies with similar names in other sources are not automatically merged.

United States · Source reference 10019-936_9b5bfec0-7b18-4839-b731-53867588ad53

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-937_9b5bfec0-7b18-4839-b731-53867588ad53

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-938_e478e54f-228b-46a1-9347-df729becf777

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-939_e478e54f-228b-46a1-9347-df729becf777

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-942_e478e54f-228b-46a1-9347-df729becf777

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-943_3d950615-927d-441e-b3be-0cebda594df5

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-944_3d950615-927d-441e-b3be-0cebda594df5

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-945_3d950615-927d-441e-b3be-0cebda594df5

CYCLOPHOSPHAMIDE

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 0338-5002_e6debc12-1f25-437c-970e-607f4953c7f7

Ceftriaxone

INJECTION, SOLUTION / Baxter Healthcare Company

United States · Source reference 0338-5003_e6debc12-1f25-437c-970e-607f4953c7f7

Ceftriaxone

INJECTION, SOLUTION / Baxter Healthcare Company

United States · Source reference 0338-3410_c8906ab2-37d2-4fde-9784-0442bf7b9565

Clindamycin phosphate

INJECTION, SOLUTION / Baxter Healthcare Company

United States · Source reference 0338-3612_c8906ab2-37d2-4fde-9784-0442bf7b9565

Clindamycin phosphate

INJECTION, SOLUTION / Baxter Healthcare Company

United States · Source reference 0338-3616_f578b16a-78b1-443f-b96a-e595ad9e145a

Clindamycin phosphate

INJECTION, SOLUTION / Baxter Healthcare Company

United States · Source reference 0338-3814_c8906ab2-37d2-4fde-9784-0442bf7b9565

Clindamycin phosphate

INJECTION, SOLUTION / Baxter Healthcare Company

United States · Source reference 0338-4114_f578b16a-78b1-443f-b96a-e595ad9e145a

Clindamycin phosphate

INJECTION, SOLUTION / Baxter Healthcare Company

United States · Source reference 0338-9777_5c81399c-bacb-48ec-8985-836412a07a6d

Cyclophosphamide

INJECTION / Baxter Healthcare Company

United States · Source reference 0338-9779_5c81399c-bacb-48ec-8985-836412a07a6d

Cyclophosphamide

INJECTION / Baxter Healthcare Company

United States · Source reference 10019-955_a466e63c-d425-4387-a41f-d1cd8023f694

Cyclophosphamide

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-956_a466e63c-d425-4387-a41f-d1cd8023f694

Cyclophosphamide

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 10019-957_a466e63c-d425-4387-a41f-d1cd8023f694

Cyclophosphamide

INJECTION, POWDER, FOR SOLUTION / Baxter Healthcare Company

United States · Source reference 0338-9555_594e9faa-bc32-42e0-9c0a-8fa9460b1e24

DEXMEDETOMIDINE HYDROCHLORIDE

INJECTION / Baxter Healthcare Company

United States · Source reference 0338-9557_594e9faa-bc32-42e0-9c0a-8fa9460b1e24

DEXMEDETOMIDINE HYDROCHLORIDE

INJECTION / Baxter Healthcare Company

United States · Source reference 43066-561_18385e15-6a52-4aec-b152-1cc136179bf4

DEXMEDETOMIDINE HYDROCHLORIDE

INJECTION / Baxter Healthcare Company

United States · Source reference 43066-565_18385e15-6a52-4aec-b152-1cc136179bf4

DEXMEDETOMIDINE HYDROCHLORIDE

INJECTION / Baxter Healthcare Company

United States · Source reference 43066-555_d0910ea1-c3e1-44f8-b8b5-1f39ffd43290

DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE

INJECTION / Baxter Healthcare Company

United States · Source reference 43066-557_d0910ea1-c3e1-44f8-b8b5-1f39ffd43290

DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE

INJECTION / Baxter Healthcare Company

United States · Source reference 0338-0063_15bd5c62-3eb4-464f-b446-76ab04fa1ab4

DOXIL

INJECTION, SUSPENSION, LIPOSOMAL / Baxter Healthcare Company

United States · Source reference 0338-0067_15bd5c62-3eb4-464f-b446-76ab04fa1ab4

DOXIL

INJECTION, SUSPENSION, LIPOSOMAL / Baxter Healthcare Company

United States · Source reference 0338-0170_37df6e9b-6f57-4f8f-b2e4-86375c021192

Dextrose

INJECTION / Baxter Healthcare Company

United States · Source reference 0338-0172_37df6e9b-6f57-4f8f-b2e4-86375c021192

Dextrose

INJECTION / Baxter Healthcare Company

Browse companies in United States →